Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

BondNews newsroom brief · 13h ago · 1 min read · via cnbc.com

Novo Nordisk CEO defended the company's decision to sue rival Eli Lilly over its weight-loss drug advertising.

Novo Nordisk CEO defended the company's decision to sue rival Eli Lilly over its weight-loss drug advertising. This story matters for Finance & Markets readers tracking bond. Reported by cnbc.com. Read the full original at the source link below.

Originally reported by cnbc.com. BondNews curates and briefs the finance & markets stories that matter. Our editorial policy →

Across the eCorp newsroom network

BrokerNews — Oil prices drop as investors weigh falling demand against Middle East tensions
BrokerNews — Bill Ackman once exited Netflix stake in a huff. Why he’s buying the streaming giant again as well as these five stocks.
Expo-News — Bill Ackman once exited his Netflix stake in a huff. He’s buying the streaming giant again, as well as these five stocks.
LargecapNews — ‘She’s desperate’: My friend’s mother died. Can she stop Medicaid from taking the family home?

Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

More from BondNews

Across the eCorp newsroom network